Brain Cancer Research Dashboard
What am I missing as a non-subscriber?
To see a full dashboard with study details and filtering, go to our DEMO page.
As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.
CannaKeys has 38 studies associated with Brain Cancer.
Here is a small sampling of Brain Cancer studies by title:
- Cannabinoid Signaling in Glioma Cells
- Concomitant Treatment of Malignant Brain Tumours With CBD - A Case Series and Review of the Literature
- Case Report: Clinical Outcome and Image Response of Two Patients With Secondary High-Grade Glioma Treated With Chemoradiation, PCV, and Cannabidiol
- Intranasal Perillyl Alcohol for Glioma Therapy: Molecular Mechanisms and Clinical Development
- Regulation Of Human Glioblastoma Cell Death By Combined Treatment Of Cannabidiol, γ-radiation And Small Molecule Inhibitors Of Cell Signaling Pathways
Components of the Brain Cancer Research Dashboard
- Dosing information available for Brain Cancer
- Chemotype guidance for treating Brain Cancer with cannabis
- Synopsis of cannabis research for Brain Cancer
- Individual study details for Brain Cancer
Ready to become a subscriber? Go to our PRICING page.
Select New Condition
Search By Keyword
Overview - Brain Cancer
Description of Brain Cancer
The location and size of cancerous brain tumors largely determine survivability and the various signs and symptoms likely to develop. As tumors grow, impairment increases. As a result, the whole body as well as the mind may be impacted. Generally speaking, the lower in the brain structure the tumor is, the poorer the survival outcome. This is because the brain's lower portions control most vital functions such as breathing and heart rate.Disease Classification
Condition: Brain CancerDisease Family: Cancer
Organ System: Nervous System
ICD-10 Chapter: Neoplasms
ICD-10 Code: C71
Brain Cancer Symptoms:
Changes in cognition, headache, visual impairments, confusion, changes in affect, seizure activities, nausea, vomiting, stroke-like deficitsAlso known as:
Neoplasm of the Brain, GliomaDrug Interactions
THC Interaction with Pharmaceutical Drugs
- THC can enhance the effects of drugs that cause sedation and depress the central nervous system, such as benzodiazepines, barbiturates, and alcohol, for example.
- THC is metabolized by and an inhibitor of a number of enzymatic liver pathways referred to as cytochrome P450. There are more than 50 enzymes belonging to this enzyme family, a number of which are responsible for the breakdown of common drugs such as antidepressants (e.g. amitriptyline, doxepine, fluvoxamine), antipsychotics (haloperidol, clozapine, stelazine), or beta-blockers (propranolol, theophylline, warfarin). Thus patients taking these classes of medication may find that THC increases the concentration and effects of these drugs as well as the duration of their effects.
- Clinical observation suggests no likely interactions with other pharmaceuticals at a total daily dose of up to 20mg THC.
CBD Interaction with Pharmaceutical Drugs
- CBD may alter action on metabolic enzymes (certain drug-transport mechanisms), and as such may alter interactions with other drugs, some of which may produce therapeutic or adverse effects. For instance, CBD interacts with the enzyme cytochrome P450 3A4 and cytochrome P450 2C19, increasing the bioavailability of anti-epileptic drugs such as clobazam (a benzodiazepine). This makes it possible to achieve the same results at significantly lower dosages, reducing treatment costs and risks of adverse effects.
- Groups of drugs affected include: anti-epileptic drugs, psychiatric drugs, and drugs affecting metabolic enzymes, for example.
- Clinical observations suggest no likely interactions with other pharmaceuticals at a total daily dose of up to 100mg CBD
Dosing Considerations
THC Dosage Considerations
- THC micro dose: 0.1 mg to 0.4 mg (0.001mg/kg to 0.005mg/kg)
- THC low dose: 0.5 mg to 5 mg (0.006mg/kg to 0.06mg/kg)
- THC medium dose: 6 mg to 20 mg (0.08mg/kg to 0.27mg/kg)
- THC high dose: 21 mg to 50+ mg (0.28mg/kg to 0.67mg/kg)
(sample conversion calculated on a person weighing 75kg)
CBD Dosage Considerations
- CBD low dose: 0.4 mg to 19 mg (0.005mg/kg to 0.25mg/kg)
- CBD medium dose: 20 mg to 99 mg (0.26mg/kg to 1.32mg/kg)
- CBD high dose: 100 mg to 800+ mg (1.33mg/kg to 10.7mg/kg)
- (upper limits tested ~1,500mg)
(sample conversion calculated on a person weighing 75kg)
Disclaimers: Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.
Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.